Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben M Eyck

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Thoracic Disease|May 14, 2019
The optimal neoadjuvant treatment of locally advanced esophageal cancerBerend J van der Wilk, Ben M Eyck, Sjoerd M Lagarde, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2021
Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomyBen M Eyck, Fredrik Klevebro, Berend J van der Wilk, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Contemporary Clinical Trials Communications|June 7, 2022
Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trialCharlène J van der Zijden, Ben M Eyck, Ate van der Gaast, et al.
The British Journal of Surgery|May 9, 2024
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysisXing Gao, Hidde C G Overtoom, Ben M Eyck, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
The British Journal of Surgery|January 13, 2022
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study GroupBerend J van der Wilk, Eliza R C Hagens, Ben M Eyck, et al.
The Journal of Pathology. Clinical Research|March 27, 2023
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet-ring cells, and/or poorly cohesive cellsMaria J Valkema, Anne-Marie Vos, Rachel S van der Post, et al.
World Journal of Surgery|February 2, 2024
Fractures and other chest wall abnormalities after thoracotomy for esophageal cancer: A retrospective cohort studySuzanne F M Van Wijck, Athiná Barza, Jefrey Vermeulen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Disease|May 14, 2019
The optimal neoadjuvant treatment of locally advanced esophageal cancerBerend J van der Wilk, Ben M Eyck, Sjoerd M Lagarde, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2021
Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomyBen M Eyck, Fredrik Klevebro, Berend J van der Wilk, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Contemporary Clinical Trials Communications|June 7, 2022
Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trialCharlène J van der Zijden, Ben M Eyck, Ate van der Gaast, et al.
The British Journal of Surgery|May 9, 2024
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysisXing Gao, Hidde C G Overtoom, Ben M Eyck, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
The British Journal of Surgery|January 13, 2022
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study GroupBerend J van der Wilk, Eliza R C Hagens, Ben M Eyck, et al.
The Journal of Pathology. Clinical Research|March 27, 2023
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet-ring cells, and/or poorly cohesive cellsMaria J Valkema, Anne-Marie Vos, Rachel S van der Post, et al.
World Journal of Surgery|February 2, 2024
Fractures and other chest wall abnormalities after thoracotomy for esophageal cancer: A retrospective cohort studySuzanne F M Van Wijck, Athiná Barza, Jefrey Vermeulen, et al.
Pageof 4